Facial Pain
Conditions
Interventions
This is a two-arm, double-blind, randomized controlled clinical trial. A total of 224 participants who meet the eligibility criteria will be randomly assigned using the Randomizer software. Both resea
Sponsors
Programa de Pós-Graduação em Odontologia da Universidade Federal do Paraná
Universidade Federal do Paraná - UFPR
Eligibility
Age
5 Years to 17 Years
Inclusion criteria
Inclusion criteria: Participants of both sexes, regardless of race or ethnicity, aged between 5 and 17 years; with a diagnosis of myalgia or myofascial pain according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD); and who present with related bruxism and anxiety
Exclusion criteria
Exclusion criteria: Participants who present with any cognitive impairment that prevents them from completing the questionnaires; whose guardians violate the study protocol, who demonstrate poor adherence to the treatment; or who provide information considered questionable by the investigators; children and adolescents with autoimmune diseases or syndromic conditions; those undergoing orthodontic treatment or those experiencing odontogenic pain; individuals using analgesic and/or anti-inflammatory medications within 48 hours prior to the start of the clinical assessment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A reduction or control of facial pain in children and adolescents is expected to be observed. | — |
Secondary
| Measure | Time frame |
|---|---|
| A reduction in pain-associated factors, such as anxiety and bruxism, is expected to be observed. | — |
Countries
Brazil
Contacts
Public ContactVanessa Lejeune
Universidade Federal do Paraná - UFPR
Outcome results
None listed